Stonepine Capital Management, LLC Top Holdings and 13F Report (2021) About Stonepine Capital Management, LLCInvestment ActivityStonepine Capital Management, LLC has $249.72 million in total holdings as of September 30, 2021.Stonepine Capital Management, LLC owns shares of 72 different stocks, but just 15 companies or ETFs make up 80% of its holdings.Approximately 68.21% of the portfolio was purchased this quarter.About 17.54% of the portfolio was sold this quarter.This quarter, Stonepine Capital Management, LLC has purchased 64 new stocks and bought additional shares in 20 stocks.Stonepine Capital Management, LLC sold shares of 25 stocks and completely divested from 15 stocks this quarter.Largest Holdings SPDR S&P Biotech ETF $102,184,000Verastem $17,502,190ADMA Biologics $17,028,900TENAX THERAPEUTICS INC $15,593,448Evolus $8,956,064 Largest New Holdings this Quarter 78464A870 - SPDR S&P Biotech ETF $102,184,000 Holding880881107 - Terns Pharmaceuticals $5,272,000 HoldingG31249108 - Establishment Labs $3,179,680 HoldingM8694L137 - SOL-GEL TECHNOLOGIES LTD $2,200,573 Holding23284F105 - CytomX Therapeutics $1,880,000 Holding Largest Purchases this Quarter SPDR S&P Biotech ETF 800,000 shares (about $102.18M)TENAX THERAPEUTICS INC 963,316 shares (about $15.40M)ADMA Biologics 1,150,000 shares (about $10.36M)Terns Pharmaceuticals 100,000 shares (about $5.27M)CAMP4 THERAPEUTICS CORP 1,160,728 shares (about $5.12M) Largest Sales this Quarter NEKTAR THERAPEUTICS 50,000 shares (about $3.60M)EDESA BIOTECH INC 657,500 shares (about $3.44M)Eledon Pharmaceuticals 858,100 shares (about $2.64M)SURROZEN INC 80,626 shares (about $2.35M)INHIBIKASE THERAPEUTICS INC 1,390,945 shares (about $2.34M) Sector Allocation Over TimeMap of 500 Largest Holdings ofStonepine Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorXBISPDR S&P Biotech ETF$102,184,000$102,184,000 â–²New Holding800,00040.9%ETFVSTMVerastem$17,502,190$3,022,171 â–²20.9%3,302,3007.0%MedicalADMAADMA Biologics$17,028,900$10,361,500 â–²155.4%1,890,0006.8%MedicalTENAX THERAPEUTICS INC$15,593,448$15,403,423 â–²8,106.0%975,2006.2%COM NEWEOLSEvolus$8,956,064$2,250,237 â–²33.6%2,179,0913.6%MedicalCAMP4 THERAPEUTICS CORP$6,128,233$5,118,810 â–²507.1%1,389,6222.5%COMNEKTAR THERAPEUTICS$6,115,750$3,597,500 â–¼-37.0%85,0002.4%COM NEWTERNTerns Pharmaceuticals$5,272,000$5,272,000 â–²New Holding100,0002.1%MedicalZVRAZevra Therapeutics$4,473,600$830,300 â–¼-15.7%480,0001.8%MedicalABEOAbeona Therapeutics$3,792,710$281,873 â–¼-6.9%846,5871.5%MedicalCRBPCorbus Pharmaceuticals$3,600,708$60,603 â–¼-1.7%383,4621.4%MedicalESTAEstablishment Labs$3,179,680$3,179,680 â–²New Holding56,0001.3%MedicalKAZIA THERAPEUTICS LTD$2,568,132$856,939 â–¼-25.0%345,1791.0%SPONSORED ADSAN2 THERAPEUTICS INC$2,441,350$294,725 â–²13.7%713,8451.0%COMAREAlexandria Real Estate Equities$2,321,0000.0%50,0000.9%FinanceACADACADIA Pharmaceuticals$2,226,0000.0%100,0000.9%MedicalSOL-GEL TECHNOLOGIES LTD$2,200,573$2,200,573 â–²New Holding27,7780.9%SHS NEWXOMAXOMA Royalty$2,180,215$1,427,335 â–¼-39.6%69,5000.9%MedicalAYTUAytu BioPharma$2,162,949$58,463 â–¼-2.6%792,2890.9%MedicalCURIS INC$2,039,462$2,006,980 â–²6,178.8%3,726,4060.8%COMHRTXHeron Therapeutics$1,921,993$931,628 â–²94.1%2,402,1910.8%MedicalCTMXCytomX Therapeutics$1,880,000$1,880,000 â–²New Holding400,0000.8%MedicalXERSXeris Biopharma$1,856,174$1,856,174 â–²New Holding320,0300.7%MedicalTELATELA Bio$1,622,696$164,436 â–²11.3%2,617,2520.6%MedicalINHIBIKASE THERAPEUTICS INC$1,608,099$2,336,787 â–¼-59.2%957,2020.6%COM NEWCRESCENT BIOPHARMA INC.$1,561,450$49,268 â–¼-3.1%85,0000.6%COMADICET BIO INC$1,511,514$13,239 â–²0.9%221,9550.6%COM NEWSIBNSiBone$1,451,995$1,451,995 â–²New Holding114,9640.6%MedicalX4 PHARMACEUTICALS INC$1,384,826$1,066,630 â–¼-43.5%335,3090.6%COM NEWOKYOOKYO Pharma$1,368,500$1,368,500 â–²New Holding850,0000.5%MedicalMNKDMannKind$1,264,935$1,053,355 â–²497.9%516,3000.5%MedicalNEUMORA THERAPEUTICS INC.$1,170,000$1,170,000 â–²New Holding600,0000.5%COMLUNGPulmonx$991,092$363,636 â–²58.0%768,2880.4%MedicalIN8BIO INC$981,850$737,808 â–²302.3%663,4120.4%COM NEWSURROZEN INC$961,436$2,348,636 â–¼-71.0%33,0050.4%COM NEWDCTHDelcath Systems$928,000$675,287 â–²267.2%100,0000.4%MedicalARDXArdelyx$898,500$898,500 â–²New Holding150,0000.4%MedicalPMVPPMV Pharmaceuticals$878,046$548,894 â–¼-38.5%708,1020.4%MedicalBIOAGE LABS INC$874,500$87,450 â–²11.1%50,0000.4%COMCONNECT BIOPHARMA HLDGS LTD$812,200$812,200 â–²New Holding310,0000.3%SHSRADIOPHARM THERANOSTICS LTD$738,9770.0%51,000,0000.3%SPONSORED ADSMXCTMaxCyte$705,783$376,298 â–²114.2%1,004,6730.3%MedicalCDXSCodexis$681,330$263,877 â–²63.2%417,9940.3%MedicalBOUNDLESS BIO INC$657,450$123,628 â–¼-15.8%597,6820.3%COMCYBIN INC$643,488$988,042 â–¼-60.6%134,0600.3%COM NEWZNTLZentalis Pharmaceuticals$629,694$455,364 â–¼-42.0%269,1000.3%MedicalPASITHEA THERAPEUTICS CORP$616,659$412,618 â–²202.2%831,3010.2%COM NEWSATELLOS BIOSCIENCE INC$563,000$563,000 â–²New Holding100,0000.2%COMPHATPhathom Pharmaceuticals$555,611$555,611 â–²New Holding50,0100.2%MedicalONKURE THERAPEUTICS INC$548,873$548,873 â–²New Holding132,5780.2%COM CL AXILIO THERAPEUTICS INC$539,602$539,602 â–²New Holding64,1620.2%COM NEWVERRICA PHARMACEUTICALS INC$527,598$1,343,310 â–¼-71.8%99,7350.2%COM SHSCADLCandel Therapeutics$502,250$502,250 â–²New Holding102,5000.2%MedicalPOCIPrecision Optics$439,000$439,000 â–²New Holding100,0000.2%MedicalQUOIN PHARMACEUTICALS LTD$352,836$163,211 â–¼-31.6%53,4600.1%SPONSORED ADSUPSTREAM BIO INC$315,000$315,000 â–²New Holding35,0000.1%COMOPUS GENETICS INC$312,530$312,530 â–²New Holding68,6880.1%COMARVNArvinas$291,500$291,500 â–²New Holding27,5000.1%MedicalPLRXPliant Therapeutics$283,059$6,804 â–¼-2.3%224,6500.1%MedicalJANXJanux Therapeutics$278,0000.0%20,0000.1%MedicalOABIOmniAb$257,551$843,020 â–¼-76.6%164,0450.1%MedicalCGENCompugen$222,159$428,343 â–¼-65.8%104,3000.1%MedicalSAB BIOTHERAPEUTICS INC$191,500$191,500 â–²New Holding50,0000.1%COM NEWEDESA BIOTECH INC$156,900$3,438,725 â–¼-95.6%30,0000.1%COM NEWCNS PHARMACEUTICALS INC$145,790$29,093 â–²24.9%61,0000.1%COMPROCESSA PHARMACEUTICALS INC$138,875$107,759 â–²346.3%55,0000.1%COM SHSCABACabaletta Bio$134,500$325,759 â–¼-70.8%50,0000.1%MedicalKALARIS THERAPEUTICS INC$117,708$117,708 â–²New Holding20,4000.0%COMELDNEledon Pharmaceuticals$107,800$2,642,948 â–¼-96.1%35,0000.0%MedicalOVIDOvid Therapeutics$88,800$138,455 â–¼-60.9%40,0000.0%MedicalEVAXION AS$73,332$1,068 â–¼-1.4%19,7130.0%SPONSORED ADSBCABBioAtla$10,527$10,527 â–²New Holding65,3870.0%MedicalINDVIndivior$0$3,588,000 â–¼-100.0%00.0%MedicalCRSPCRISPR Therapeutics$0$2,622,000 â–¼-100.0%00.0%MedicalRAREUltragenyx Pharmaceutical$0$2,300,000 â–¼-100.0%00.0%MedicalDAWNDay One Biopharmaceuticals$0$1,864,000 â–¼-100.0%00.0%MedicalSPRUCE BIOSCIENCES INC$0$1,719,726 â–¼-100.0%00.0%COM NEWENTAEnanta Pharmaceuticals$0$1,577,000 â–¼-100.0%00.0%MedicalMISTMilestone Pharmaceuticals$0$1,338,585 â–¼-100.0%00.0%MedicalGERNGeron$0$1,063,656 â–¼-100.0%00.0%MedicalKEZAR LIFE SCIENCES INC$0$982,366 â–¼-100.0%00.0%COM NEWSMLRSemler Scientific$0$764,500 â–¼-100.0%00.0%MedicalGOSSGossamer Bio$0$634,787 â–¼-100.0%00.0%MedicalFENCAdherex Technologies$0$385,000 â–¼-100.0%00.0%MedicalKIORA PHARMACEUTICALS INC$0$258,354 â–¼-100.0%00.0%COMTNYATenaya Therapeutics$0$250,449 â–¼-100.0%00.0%MedicalXLOXilio Therapeutics$0$80,838 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
